Evidence map›Paper›PMID 42296160›Full record

ArticlePloS one2026

Unlocking precision diagnostics: A multimodal framework integrating metabolomics with advanced machine learning techniques.

Parisa Shahnazari, Kaveh Kavousi, Hamid Reza Khorram Khorshid, Bahram Goliaei, Reza M Salek

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Parisa ShahnazariLaboratory of Complex Biological Systems and Bioinformatics (CBB), Department of Bioinformatics, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.ORCID https://orcid.org/0000-0001-6109-8759
Kaveh KavousiLaboratory of Complex Biological Systems and Bioinformatics (CBB), Department of Bioinformatics, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Hamid Reza Khorram KhorshidGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Bahram GoliaeiLaboratory of Biophysics and Molecular Biology, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Iran.
Reza M SalekSchool of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, England.ORCID https://orcid.org/0000-0001-8604-1732

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrating multiple omics modalities is a crucial strategy in cancer research, particularly in metabolomics, enabling early detection and detailed exploration of cancer biomarker signatures. This study evaluates five strategies for integrating metabolomics data from liquid chromatography-mass spectrometry, gas chromatography-mass spectrometry, and nuclear magnetic resonance. Deep Transfer Learning and Multiple Kernel Learning demonstrated superior performance, significantly improving classification accuracy, sensitivity, and robustness compared to single-modality analyses. Deep Transfer Learning employed a custom autoencoder for feature extraction followed by artificial neural network classification, while Multiple Kernel Learning optimized kernel matrices across different modalities. Feature extraction in the Deep Transfer Learning approach, combined with the selection of important features and subsequent analysis, revealed elevated levels of monounsaturated phospholipids such as phosphatidylcholine 30:1, phosphatidylethanolamine 32:1, and sphingomyelin 32:1 in HER2-positive cases. Additionally, β-alanine, gluconic acid, and N-acetylaspartic acid were increased, whereas 5'-deoxy-5'-methylthioadenosine and nicotinamide were decreased. These methods advance cancer detection, biomarker discovery, and the development of precise diagnostic and therapeutic tools while offering robust and adaptable strategies for multi-omics data integration across diverse biological datasets.

Indexed as

Machine LearningMetabolomicsNeoplasmsTransfer Machine LearningBiomarkers, TumorGas Chromatography-Mass SpectrometryHumansLiquid Chromatography-Mass SpectrometryMagnetic Resonance SpectroscopyMultiomicsNeural Networks, ComputerBiomarkers, Tumor

Identifiers

PMID42296160
PMCPMC13268153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.